Atea Pharmaceuticals, Inc. (AVIR) vs Shoulder Innovations, Inc. (SI)
A side-by-side comparison of Atea Pharmaceuticals, Inc. and Shoulder Innovations, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVIR
Atea Pharmaceuticals, Inc.
$5.08HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
SI
Shoulder Innovations, Inc.
$19.78HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Total return — AVIR vs SI
growth of $100 · dividends reinvested · last 1yAVIR +39.8% (+39.8%/yr)SI +30.2% (+30.2%/yr)AVIR compounded faster over this window
AVIR SI
AVIR vs SI: by the numbers
- •SI is the larger company ($410M vs $406M market cap).
- •Both run net losses; AVIR's is the smaller (0.00% vs -58.33% net margin).
Metrics side by side
Valuation
| Metric | AVIR | SI |
|---|---|---|
| P/S ratio | N/A | 6.83 |
| P/B ratio | 1.99 | 3.30 |
Profitability
| Metric | AVIR | SI |
|---|---|---|
| Gross margin | 0.00% | 77.34% |
| Operating margin | 0.00% | -58.53% |
| Net margin | 0.00% | -58.33% |
| ROE | -80.96% | -28.18% |
| ROIC | -89.93% | -25.26% |
Growth (annualized)
| Metric | AVIR | SI |
|---|---|---|
| Total return CAGR (5Y) | -34.44% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.